Medication info
Glimel M Tablet 2/500 mg

Glimel M Tablet 2/500 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
White oblong film-coated tablets
Packaging
30 tablets/PTP
Approval status
Active

MFDS item code 201107272 · Approved 2011.09.28 · Insurance code 642506670

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes who find it difficult to manage blood sugar with diet and exercise alone, by administering glymepride and metformin in combination.

How to take

Adult dose

Take this medicine 1~2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, and the dose may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose of this medicine was glimepiride/metformin hydrochloride 2mg/500mg, and there is experience with gradually increasing the dose according to blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. Glimepiride as a single agent generally provides little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next scheduled administration.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia, so it should be avoided especially in cases of acute renal dysfunction. If symptoms of dehydration, severe diarrhea, vomiting, or fever occur, it is advisable to temporarily discontinue use of this medication and consult a physician. Patients with decreased renal function or the elderly should have their kidney function checked regularly while using this medication, and it should not be administered if kidney function is below 45 mL/min/1.73 m². Caution is necessary for patients with cardiovascular disease, as this medication may increase the risk of cardiovascular death. Patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, women who are pregnant or breastfeeding, and patients with severe renal impairment should not take this medication. This medication should be discontinued before and after tests using radioactive iodine contrast agents and it should be waited until kidney function returns to normal. Patients at high risk for hypoglycemia, malnourished individuals, those with irregular meal intake, engaging in vigorous exercise, or those consuming alcohol should be carefully monitored when taking this medication. Gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.) are common with this medication, and initially, the dosage may be gradually increased or taken with meals to reduce symptoms. If allergic reactions occur, inform a physician immediately and discontinue use. Regular monitoring of serum vitamin B12 levels is recommended, as vitamin B12 deficiency may occur. This medication may interact with various drugs. If you are taking other medications, you must inform your physician or pharmacist. It is safest not to use this medication during pregnancy or breastfeeding, and insulin therapy should be considered if necessary. Children and the elderly require special caution when using this medication, particularly the elderly, who require careful dosage adjustment and monitoring due to decreased kidney function. In case of overdose, hypoglycemia or lactic acidosis may occur, so contact a medical facility immediately and receive appropriate treatment. While taking this medication, regular meals and exercise, as well as regular blood sugar and kidney function checks, are required, and care should be taken for hypoglycemia symptoms when driving or operating machinery. Keep out of reach of children, and do not transfer to other containers.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorder, erythema, itching, hives, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, decreased vitamin B12, peripheral neuropathy, increased liver enzymes, liver function impairment, cholestasis, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased Thyroid-Stimulating Hormone levels, magnesium deficiency in case of diarrhea, encephalopathy, hair loss, weight gain, headache due to hypoglycemia, severe hunger, fatigue, sleep disturbances, instability, aggression, attention deficit, inability to focus, abnormal reaction, depression, confusion, speech impairment, aphasia, tremors, paralysis, sensory disturbances, dizziness, loss of self-regulation, delirium, cerebral seizures, loss of consciousness, coma, weak respiration, slow pulse, sweating, clammy skin, rapid pulse, hypertension, palpitations, angina pectoris, deep vein thrombosis, abdominal pain, abdominal distension, vomiting, dyspepsia, dizziness, palpitations, leg edema, cardiac arrest, rectal carcinoma, vertigo, liver dysfunction, arthralgia, facial swelling, erectile dysfunction, facial flush, gastritis, pancreatitis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is recommended to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oblong film-coated tablets

Package unit

30 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.